These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12426254)

  • 1. Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor.
    Terashima T; Amakawa K; Matsumaru A; Yamaguchi K
    Chest; 2002 Nov; 122(5):1566-70. PubMed ID: 12426254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.
    Cai C; Yang J; Hu S; Zhou M; Guo W
    Lung; 2007; 185(2):105-12. PubMed ID: 17393242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
    Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
    Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a cysteinyl leukotriene antagonist, pranlukast hydrate, on acetaldehyde-induced bronchoconstriction in asthmatic patients.
    Myou S; Fujimura M; Kamio Y; Kita T; Katayama N; Abo M; Yoshimi Y; Nishitsuji M; Nomura S; Hashimoto T; Nakao S
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):41-4. PubMed ID: 11487307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
    Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
    Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma.
    Kohrogi H; Iwagoe H; Fujii K; Hamamoto J; Fukuda K; Hirata N; Kawano O; Matsumoto M; Suga M; Ando M
    Respirology; 1999 Sep; 4(3):319-23. PubMed ID: 10489683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
    J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics.
    Yamauchi K; Tanifuji Y; Pan LH; Yoshida T; Sakurai S; Goto S; Kuroda S; Kobayashi H; Inoue H
    J Asthma; 2001 Feb; 38(1):51-7. PubMed ID: 11256554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
    Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a leukotriene antagonist, pranlukast hydrate, on exercise-induced asthma for 14 days].
    Suguro H; Majima T; Hattori T; Ichimura K; Hashimoto N; Horie T
    Arerugi; 2000 Aug; 49(8):646-52. PubMed ID: 11021016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
    Yoo SH; Park SH; Song JS; Kang KH; Park CS; Yoo JH; Choi BW; Hahn MH;
    Respirology; 2001 Mar; 6(1):15-21. PubMed ID: 11264758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist.
    Nakasato H; Ohrui T; Sekizawa K; Matsui T; Yamaya M; Tamura G; Sasaki H
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):585-8. PubMed ID: 10482831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha.
    Tanaka H; Saito T; Kurokawa K; Teramoto S; Miyazaki N; Kaneko S; Hashimoto M; Abe S
    Allergy; 1999 May; 54(5):489-94. PubMed ID: 10380781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.